Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06753045 · ClinicalTrials.gov registry record
Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology
A clinical trial of Heart Diseases, sponsored by Tulane University.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 3
- Study locations
NCT06753045: Recruiting study of Heart Diseases, sponsored by Tulane University.
NCT06753045 is a study of Heart Diseases that is actively recruiting participants, run by Tulane University. The registered enrollment target is 10,000 participants, above the 5,415-participant average among 85 other Heart Diseases trials with a reported enrollment target (85% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06753045, a study of Heart Diseases, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardiovascular diseases and related conditions by SAMSUNG and Tulane. The study will include up to ten thousand adult subjects tasked with wearing a smartwatch to collect digital biomarker data over a 1 year period. Concurrent to smartwatch data collection, subjects will be instructed to complete questionnaires via the Huma Decentralized Clinical Trials (HUMADCT) platform. There are no investigational drugs or interventions administered as part of this study.
Primary Outcome
These endpoints will be collected from the electronic health records using the International Classification of Diseases Tenth Edition (ICD-10) codes, prompted by a patient survey conducted via the use of a smart phone app. The investigators will use the the patient's survey answers as a prompt to check the EMR. If in the survey a patient mentions they had a cardiovascular incidence, then the EMR data will be checked to see the reports from the ER visit to confirm the incidence. The number that w
Conditions Studied
Interventions
- OTHER Smartwatch
Study Locations (3)
Louisiana
- East Jefferson General Hospital - New Orleans
- Tulane University Medical Group Clinics - New Orleans
- University Medical Center - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2024-10-08 |
| Est. Completion | 2027-10 |
What NCT06753045 shows while recruiting
NCT06753045 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 5,415-participant average among 85 other Heart Diseases trials with a reported enrollment target (85% higher).
The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 1 intervention - of which Smartwatch is the first listed.
NCT06753045 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT06753045 about?
NCT06753045 is a clinical study titled "Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology". This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardio...
What is the current status of trial NCT06753045?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2024-10-08. Estimated completion is 2027-10.
What conditions does trial NCT06753045 study?
This clinical trial studies the following conditions: Heart Diseases.
What interventions are being tested in trial NCT06753045?
The interventions under investigation include: Smartwatch (OTHER).
Who is sponsoring clinical trial NCT06753045?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06753045 being conducted?
This trial has 3 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06753045's enrollment target sits among peer trials
10,000 5th of 85 higher than 81 of 85 other Heart Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Lumason® Infusion vs. Bolus Administrations
RECRUITING · Phase 3
-
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI